Knoll wins award for support of pharmacy
WASHINGTON - The American Pharmaceutical Association awarded Mount Olive, NJ-based Knoll Pharmaceutical Co. the 15th annual H.A.B. Dunning Award.
WASHINGTON - The American Pharmaceutical Association awarded Mount Olive, NJ-based Knoll Pharmaceutical Co. the 15th annual H.A.B. Dunning Award.
The award, which recognizes exemplary contributions to the practice of pharmacy by a pharmaceutical manufacturer or provider of support products and services, will be presented during the association's 145th annual meeting and exposition in Miami Beach, FL, in March.
Knoll was nominated by the Texas Pharmacy Association for its support of educational consumer awareness and independent business programs. The association also benefited from Knoll's funding of expanded educational facilities, which allowed the association to increase its capacity by one-third. In addition, Knoll sponsored a family night for pharmacists and their families to encourage networking; an appreciation banquet for pharmacists; and a county art auction that benefited the surrounding communities.
"In each contribution, Knoll's people are with us every step of the way - evaluating the programs, looking for ways to make them better and encouraging other organizations to support our pharmacists," wrote Luther Parker, association president, and Paul Davis, association executive director, in explanation of the nomination. "We believe Knoll deserves this award not only because of the numerous contributions the company made in 1997, but also because of Knoll's history of support, and its future commitment to the practice of pharmacy." PR
Phase III Trials Show Povorcitinib Significantly Improves Hidradenitis Suppurativa Outcomes
March 19th 2025In the Phase III STOP-HS1 and STOP-HS2 trials, results show that patients treated with povorcitinib for hidradenitis suppurativa experienced a ≥50% reduction in the total abscess and inflammatory nodule count.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
